| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Bulgaria lags behind Europe in pollution and smoking targets
|
van Dorn, Aaron
|
|
2014
|
2 |
3 |
p. 182-183
2 p.
|
artikel
|
| 2 |
Coming off the GOLD standard
|
Burney, Peter
|
|
2014
|
2 |
3 |
p. 174-176
3 p.
|
artikel
|
| 3 |
COPD: no gene left unturned
|
Ferrarotti, Ilaria
|
|
2014
|
2 |
3 |
p. 171-172
2 p.
|
artikel
|
| 4 |
Dorothy Hansine Andersen
|
Clague, Stephanie
|
|
2014
|
2 |
3 |
p. 184-185
2 p.
|
artikel
|
| 5 |
Effectiveness of tuberculosis preventive therapy in gold miners
|
Yaqub, Farhat
|
|
2014
|
2 |
3 |
p. 181-
1 p.
|
artikel
|
| 6 |
Effect of rare variants in ADRB2 on risk of severe exacerbations and symptom control during longacting β agonist treatment in a multiethnic asthma population: a genetic study
|
Ortega, Victor E
|
|
2014
|
2 |
3 |
p. 204-213
10 p.
|
artikel
|
| 7 |
Estimation and application of the minimum clinically important difference in COPD
|
Jones, Paul W
|
|
2014
|
2 |
3 |
p. 167-169
3 p.
|
artikel
|
| 8 |
First stem cell treatment for BPD in preterm infants
|
Marshall, Hilary
|
|
2014
|
2 |
3 |
p. 181-
1 p.
|
artikel
|
| 9 |
Might statins prevent delirium in intensive care units?
|
Furlow, Bryant
|
|
2014
|
2 |
3 |
p. 180-
1 p.
|
artikel
|
| 10 |
Minimum clinically important difference for the COPD Assessment Test: a prospective analysis
|
Kon, Samantha S C
|
|
2014
|
2 |
3 |
p. 195-203
9 p.
|
artikel
|
| 11 |
N-acetylcysteine in COPD may be beneficial, but for whom?
|
Cazzola, Mario
|
|
2014
|
2 |
3 |
p. 166-167
2 p.
|
artikel
|
| 12 |
Phenotyping of COPD: challenges and next steps
|
Bourbeau, Jean
|
|
2014
|
2 |
3 |
p. 172-174
3 p.
|
artikel
|
| 13 |
Responsible mining
|
Harrison, Natalie
|
|
2014
|
2 |
3 |
p. 185-
1 p.
|
artikel
|
| 14 |
Risk loci for chronic obstructive pulmonary disease: a genome-wide association study and meta-analysis
|
Cho, Michael H
|
|
2014
|
2 |
3 |
p. 214-225
12 p.
|
artikel
|
| 15 |
Role of interleukin 33 in respiratory allergy and asthma
|
Makrinioti, Heidi
|
|
2014
|
2 |
3 |
p. 226-237
12 p.
|
artikel
|
| 16 |
Should we use ADRB2 variation to stratify asthma treatment?
|
Hall, Ian P
|
|
2014
|
2 |
3 |
p. 169-171
3 p.
|
artikel
|
| 17 |
Smoking and mental illness—time to break the link
|
Burki, Talha Khan
|
|
2014
|
2 |
3 |
p. 177-
1 p.
|
artikel
|
| 18 |
The low-hanging fruits—are they out of reach?
|
The Lancet Respiratory Medicine,
|
|
2014
|
2 |
3 |
p. 165-
1 p.
|
artikel
|
| 19 |
Towards an ecology of the lung: new conceptual models of pulmonary microbiology and pneumonia pathogenesis
|
Dickson, Robert P
|
|
2014
|
2 |
3 |
p. 238-246
9 p.
|
artikel
|
| 20 |
Tuberculosis in black and white
|
Astudillo, Olaya
|
|
2014
|
2 |
3 |
p. 186-
1 p.
|
artikel
|
| 21 |
Twice daily N-acetylcysteine 600 mg for exacerbations of chronic obstructive pulmonary disease (PANTHEON): a randomised, double-blind placebo-controlled trial
|
Zheng, Jin-Ping
|
|
2014
|
2 |
3 |
p. 187-194
8 p.
|
artikel
|
| 22 |
Uranium mines: lung disease and mistrust among Native Americans
|
Furlow, Bryant
|
|
2014
|
2 |
3 |
p. 178-179
2 p.
|
artikel
|
Tijdschrift beschrijving